IgE-ELISAs of serum samples from patients with asthma, rhinitis, urticarial, and dermatitis allergy manifestations (N = 10 per manifestation) revealed no correlation between the IgE binding activity of Peptide-1–32aa from Der p 24 and allergic disease symptoms (Fig. 5c). This evidence concerns the gene IGHE and skin disorder.